C-B5LQJunevity
siRNA, gene network reset, machine learning
reprogrammingrna therapeutic
Loading
Loading section...0-100 chain-logic scale · 15 dimensions · scored on public evidence
←All companiesC-B5LQ
C-B5LQC-B5LQsiRNA, gene network reset, machine learning
0-100 chain-logic scale · 15 dimensions · scored on public evidence
Junevity siRNA, gene network reset, machine learning
Junevity focuses on complex and age-related diseases involving widespread gene dysregulation. Its RESET platform discovers therapeutic candidates using human disease data, genetics, machine learning, and siRNA. The company states that its founders showed repression of a single transcription factor can restore gene networks to a healthy state in a human cell model of aging.
The published score reflects a curated read of public evidence across 16 dimensions. Each dimension below shows the rationale we used. Disagree with a reading? Tell us where we are wrong →
Higher up = higher Eternal Search score. Further right = closer to achieving real longevity outcomes (early mechanism → translational → near-term readout). Bubble size = capital deployed. Watch for MISMATCHES: big bubbles on the left are well-capitalized but far from goals; small bubbles on the right are doing more with less.
Junevity — Far from goals · Bottom quartile. Derived deterministically from 4 extracted project(s). Most-advanced status: exploratory. Band: far. Aging-relevance not LLM-reviewed in this pass.
Source: Deterministic